EUVIMEDEUVIMED entdecken
Crossref

New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions

Jennifer Abbasi

JAMA · 20.08.2024 · 332 (7) · 519

DOI: 10.1001/jama.2024.11510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 20.08.2024. Verfasst von Jennifer Abbasi. Beteiligte Einrichtung: Director, Medical News & Perspectives, JAMA. Hauptthemen laut MEDLINE: Continuous Glucose Monitoring, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Retinopathy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Medical News article is an interview with Robert Gabbay, MD, PhD, the American Diabetes Association’s chief scientific and medical officer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Glucose MonitoringDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic RetinopathyGlucagon-Like Peptide-1 Receptor AgonistsInsulinHumansBlood GlucoseCongresses as TopicDrug ApprovalGlucagon-Like Peptide 1ObesityOff-Label UseRenal Insufficiency, ChronicSleep Apnea, Obstructive

Substanzen

Blood GlucoseGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsInsulin

Autor:innen und Institutionen

  • Director, Medical News & Perspectives, JAMA.

Zitieren

APA

Abbasi, J. (2024). New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions. JAMA, 332(7), 519. https://doi.org/10.1001/jama.2024.11510

Vancouver

Abbasi J. New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions. JAMA. 2024;332(7):519. doi:10.1001/jama.2024.11510

BibTeX
@article{Abbasi2024,
  author = {Abbasi, Jennifer},
  title = {New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {7},
  pages = {519},
  doi = {10.1001/jama.2024.11510}
}
Kostenlos starten →